Erectile Dysfunction Drugs Market Growth Dominated Pfizer Inc.: By Size, Drivers, Share And Forecast To 2023

“Erectile Dysfunction Drugs Market”
MRFR is the Leading Brand in The Research Company who Recently Published Erectile Dysfunction Drugs Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023

Market Research Future (MRFR) has published a research report about the Global Erectile Dysfunction Drugs Market that predicts growth for this market with 6.5% CAGR between 2017 and 2023. In terms of cash, the market has been anticipated to rise to the US $ 2.95 bn by the end of the forecast period. Inability to keep the firm erection firm enough during sexual intercourse is known as erectile dysfunction or impotence. This is a common disorder, and there are remedies to cure it due to the availability of various drugs.

The key factors that are aiding the growth of Global Erectile Dysfunction Drugs Market include an increase in the competition among the major market players, increasing number of men suffering from erectile dysfunction, and a number of drugs available in the market. However, some factors that can harm the market growth include the availability of counterfeit drugs, the increasing manufactures of generic drugs in the market, and patent expiry of a number of blockbuster drugs.

Global Erectile Dysfunction Drugs Market – Major Players

Key players in Erectile Dysfunction Drugs Market are

  • Pfizer Inc. (U.S)
  • Bayer AG (Germany)
  • Eli Lily & Co. (U.S)
  • Dong–A Pharmaceutical Co. Ltd. (South Korea)
  • Apricus Biosciences Inc. (U.S)
  • S.K. Chemicals Co. Ltd. (South Korea)
  • Apricus Biosciences Inc. (U.S)

Get Sample Report @

Global Erectile Dysfunction Drugs Market – Segmentation

Global Erectile dysfunction drugs market has been segmented on the basis of product which includes Viagra, Cialis, Levitra, Stendra, Zydena and other drugs and on the basis of end users the market is segmented into Hospitals, clinics, pharmaceutical companies and others.

Industry News:

In a first-to-file launch, Teva Pharmaceuticals has announced a generic version of Cialis® (Eli Lilly) tadalafil tablets (2.5 mg, 5 mg, 10 mg, 20 mg) for the US market. Tadalafil tablets are for the treatment of erectile dysfunction. 27 SEP 2018

A bid to make an erectile dysfunction drug sildenafil (including Viagra, Pfizer), available without a prescription has been rejected by the Therapeutic Goods Administration (TGA) on the basis it could delay the diagnosis of cardiovascular disease, which “cannot be diagnosed by a pharmacist.” 27 SEP 2018

Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City.  It is among the world’s largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Viagra drug for erectile dysfunction treatment manufactured by the company. In June 1, 2017, Pfizer Limited (India) acquired AstraZeneca’s Neksium.

Bayer AG is a chemical, pharmaceutical and life science company. It is one of the major players manufacturing drugs for erectile dysfunction. Levitra is a product offered by the company for this disorder. It is a major competitor for Pfizer in this market.

Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company manufactures a drug named Cialis for erectile dysfunction. In January 2017, the Eli Lilly Company was awarded as world’s most ethical company.

Global Erectile Dysfunction Drugs Market – Regional Analysis

Via regional segmentation, the global erectile dysfunction drugs market has been segmented into continent-based regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East and Africa (MEA). Among these, The Americas is the largest market. In the Americas, North America is a bigger market than South America due to advanced technology and advanced medical facilities. This factor enables North America to emerge as the largest market on its own. Many key market players are based in North America, most of them in the United States of America (USA), the biggest economy in this region. All kinds of advanced medical facilities make North America an ideal market and hence, all kinds of drugs including erectile dysfunction drugs are always in demand, given the fact that many people in North America indulge in casual sex. After the USA, Canada is the most significant country-based market in North America.

Europe is the second largest market for erectile dysfunction drugs as it is technologically advanced but not as advanced as North America. Its high density of population makes it a suitable market. Due to reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. The most important country-specific markets in Western Europe that are France, Germany, Italy, Spain, and the United Kingdom (UK).

During the forecast period, the Asia Pacific market is expected to emerge as the fastest growing market. The unhealthy lifestyle in this region causes erectile dysfunction among many people. The biggest factor that causes hindrance in the growth of the market in some Asian countries is the stigma and shame associated with it as in certain cultures, men suffering from this disorder are not considered as real men. Given the huge population of countries like China and India, the market in this region is set to grow. Other important country-specific markets in this region are Australia, Japan, and South Korea, followed by the rest of Asia Pacific.

Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @

The MEA region is a small market. The reasons for the low market in this region include lack of awareness about erectile dysfunction, lack of education, lack of technological development, political instability, poor healthcare, social stigma, and healthcare not considered a priority by most governments. In this region, the significant country-specific markets are Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by the rest Of the MEA region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India